Chemerin and Interleukin-6 Levels of Gingival Crevicular Fluid in Obese Individuals Following Periodontal Treatment
NCT ID: NCT02660814
Last Updated: 2016-01-22
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
EARLY_PHASE1
72 participants
INTERVENTIONAL
2014-07-31
2015-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Gingival Crevicular Fluid Vaspin and Omentin Levels in Obese Patients With Chronic Periodontitis
NCT02563171
Chemerin and IL-6 Levels in Diabetes and Periodontitis
NCT02596581
Analysis of Gingival Crevicular Fluid
NCT05325905
Gingival Crevicular Fluid, Salivary, and Serum Biomarkers Levels in Periodontal Treatment
NCT05395455
Effect of Non-Surgical Periodontal Treatment on Gingival Crevicular Fluid and Serum Biomarker Levels
NCT06175624
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
TREATMENT
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Healthy periodontium without obesity
GCF samples were taken at baseline
Intervention: Gingival crevicular fluid collection
Gingival crevicular fluid collection
GCF collection with filter paper (Periopaper) using the intracrevicular method.
Chronic periodontitis without obesity
GCF samples were taken before and after treatment chronic periodontitis patients.
Intervention: Non-surgical periodontal treatment (SRP and oral hygiene instructions)
Non-surgical periodontal treatment
1. SRP under local anaesthesia, in a total of 2-3 clinical visits.
2. Oral hygiene instructions including the modified Bass technique, regular toothpaste, and an appropriate interdental cleaning device with dental floss and interdental brush.
Gingival crevicular fluid collection
GCF collection with filter paper (Periopaper) using the intracrevicular method.
Healthy periodontium with obesity
GCF samples were taken at baseline
Intervention: Gingival crevicular fluid collection
Gingival crevicular fluid collection
GCF collection with filter paper (Periopaper) using the intracrevicular method.
Chronic periodontitis with obesity
GCF samples were taken before and after treatment chronic periodontitis patients.
Intervention: Non-surgical periodontal treatment (SRP and oral hygiene instructions)
Non-surgical periodontal treatment
1. SRP under local anaesthesia, in a total of 2-3 clinical visits.
2. Oral hygiene instructions including the modified Bass technique, regular toothpaste, and an appropriate interdental cleaning device with dental floss and interdental brush.
Gingival crevicular fluid collection
GCF collection with filter paper (Periopaper) using the intracrevicular method.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Non-surgical periodontal treatment
1. SRP under local anaesthesia, in a total of 2-3 clinical visits.
2. Oral hygiene instructions including the modified Bass technique, regular toothpaste, and an appropriate interdental cleaning device with dental floss and interdental brush.
Gingival crevicular fluid collection
GCF collection with filter paper (Periopaper) using the intracrevicular method.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. had a minimum of 20 natural teeth, excluding third molars
3\) glycosylated hemoglobi levels \<6%
4\) fasting plasma glucose levels \<100 mg/dl.
5-) Criteria for the periodontal healthy group were GI = 0, PPD≤ 3 mm, and no signs of attachment and bone loss by clinical and radiographic examination.
6-) Criteria for the chronic periodontitis group were clinical signs of inflammation (red color and swelling of the gingival margin), GI ≥ 2, PPD and CAL ≥ 5 mm, and bone loss affecting \>30% of the existing teeth on clinical and radiographic examination.
7-) Criteria for obese groups were 30≤ BMI \<40 kg/m2, and concomitant WHR ≥0.85 for females and WHR ≥0.90 for males.
8-) Criteria for normal-weight groups were 20≤ BMI \<25 kg/m2, and WHR below that determined for obesity.
Exclusion Criteria
2. Periapical pathologies
3. Excessive forces including mechanical forces from orthodontics and occlusion
4. Systemic diseases (e.g., diabetes mellitus; cancer; human immunodeficiency virus; or disorders that could affect adipokines levels and the periodontal conditions)
5. Chronic high-dose steroid therapy, radiation or immunosuppressive therapy
6. Pregnancy, lactation
7. Smoking within the past five years, or allergy or sensitivity to any drug
8. Had no history of periodontal therapy or drug therapy (e.g., anti-inflammatories, antibiotics, or any other pharmacological treatment) for at least six months
32 Years
53 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Umut BALLI
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Umut BALLI
Principal Investigator
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2014-115-17/06.
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.